Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/6/2025

Surgical Indications for Mitral Valve Replacement in Congestive Heart Disease with Mitral Regurgitation

Primary Mitral Regurgitation

  • The American College of Cardiology recommends surgery for symptomatic patients with severe mitral regurgitation and LVEF >30%, and for asymptomatic patients with LV dysfunction (LVEF 30-60% or LVESD ≥40 mm), with mitral valve repair strongly preferred over replacement when technically feasible 1, 2, 3
  • Surgery is mandatory for all symptomatic patients with severe primary MR and LVEF >30% (Class I recommendation) 1, 2, 4
  • Symptoms include decreased exercise tolerance, exertional dyspnea, or heart failure 4
  • Severe MR is defined by: vena contracta ≥0.7 cm, regurgitant volume ≥60 mL, regurgitant fraction ≥50%, or ERO ≥0.40 cm² 4
  • Surgery is required when LVEF falls to 30-60% and/or LVESD ≥40 mm to prevent irreversible ventricular damage 1, 2, 4
  • For patients of small stature, adjust LVESD threshold to 22 mm/m² body surface area 5
  • Surgery is reasonable when new-onset atrial fibrillation develops 1, 5
  • Surgery is reasonable when resting pulmonary hypertension (PA systolic pressure >50 mmHg) is present 1, 5

Secondary Mitral Regurgitation

  • The European Heart Journal indicates that medical optimization is necessary before considering surgery for secondary MR, including ACE inhibitors/ARBs, beta-blockers, and aldosterone antagonists 4, 5
  • Cardiac resynchronization therapy must be implemented if the patient meets device indications 4, 5
  • Reassess MR severity after medical optimization, as it may improve significantly 4
  • Surgery is indicated when severe secondary MR is present in patients already undergoing CABG with LVEF >30% (Class I recommendation) 2, 3, 4
  • Isolated mitral valve surgery may be considered for severely symptomatic patients (NYHA III-IV) who remain symptomatic despite optimal medical therapy, but this is a weaker recommendation (Class IIb) 4, 5

Repair vs Replacement Decision

  • The American College of Cardiology recommends mitral valve repair over replacement in all scenarios where durable repair is achievable 1, 4
  • Repair is mandatory when primary MR is limited to the posterior leaflet 1, 4
  • Repair is preferred for anterior leaflet or bileaflet involvement when successful, durable repair is possible 1, 4

Concomitant Surgery

  • The American College of Cardiology indicates that concomitant mitral valve repair or replacement is indicated for severe primary MR 1
  • Concomitant repair is reasonable even for moderate primary MR 1
  • For severe secondary MR with LVEF >30%, concomitant surgery is indicated during CABG 2, 3, 5